Lactium® (Alpha-Casozepine Milk Peptide)

Bovine αs1-casein tryptic hydrolysate
Evidence Level
Limited
3 Clinical Trials
7 Documented Benefits
2/5 Evidence Score

Branded milk-derived bioactive peptide from Ingredia Nutritional (France). A tryptic hydrolysate of bovine αs1-casein containing the α-casozepine decapeptide with benzodiazepine-like activity, discovered by observing infants' calmed state after milk feeding. Clinical studies confirm stress and sleep benefits at 150-300 mg/day. It binds the GABA-A benzodiazepine site without addiction or sedation.

Studied Dose 150–300 mg/day (AM/PM split or evening for sleep); 300 mg/day for insomnia; 150 mg single dose for acute stress.
Active Compound α-casozepine (Tyr-Leu-Gly-Tyr-Leu-Glu-Gln-Leu-Leu-Arg, decapeptide from positions 91–100 of bovine αs1-casein), released by tryptic hydrolysis; Lactium® standardized for α-casozepine content.

Benefits

Faster stress recovery in healthy adults

Lactium at 150-300 mg/day reduces perceived stress and anxiety scores in healthy adults experiencing work or life stress. The signature finding is faster physiological recovery from stress — blood pressure and heart rate return to baseline more quickly after a stressful event. Effect is modest but consistent across multiple trials. Reasonable consideration for situational stress management; not a replacement for clinical anxiety treatment when symptoms are severe or persistent.

Chronic insomnia improvement

In adults with chronic insomnia, Lactium over 4 weeks improves both subjective sleep measures (insomnia severity, sleep quality scores, daytime sleepiness) and objective polysomnography measurements. Notable that the recent rigorous trial used objective sleep recording — many sleep supplements rely solely on self-report questionnaires. Reasonable consideration for adults with chronic insomnia, particularly when stress reactivity contributes to the sleep difficulty.

Sleep enhancement combined with L-theanine

Lactium combined with L-theanine produces additive sleep benefits beyond either alone. The two compounds work through complementary calming pathways: Lactium acts on GABA receptors while L-theanine modulates alpha brain waves and glutamate. Reasonable stack for adults with sleep difficulties driven by an overactive mind, particularly when single-ingredient sleep aids haven't worked. Combination products marketed for sleep often include both compounds for this reason.

Combined Zizyphus formulation for sleep

Lactium combined with Zizyphus jujuba (the LZComplex3 formulation) produces measurable sleep quality improvements in randomized placebo-controlled testing. Zizyphus has its own traditional use for sleep in East Asian medicine. Limited sample sizes mean the combination is supportive rather than definitive evidence. Reasonable to try if you're already considering Lactium and want a botanical pairing.

Sleep disturbance — replicated in crossover trials

Multiple randomized crossover trials in different populations (including Korean adults) confirm Lactium's effect on sleep disturbance. Crossover designs provide robust within-subject evidence — each participant serves as their own control, which removes some of the noise from group-level comparisons. Strengthens the overall sleep evidence base across diverse populations rather than being tied to a single demographic or methodology.

Vitamin B6 combination — pediatric and youth applications

Lactium combined with vitamin B6 is used in some clinical practice (particularly Eastern European pediatric medicine) for functional nervous system disorders, sleep difficulties, and stress in younger populations. Lactium has no sedation, addiction, or withdrawal risk — making it a more conservative option than benzodiazepines for pediatric and adolescent use. Limited rigorous Western pediatric RCTs; supportive clinical practice base in some regions.

Better safety profile than benzodiazepines

Unlike benzodiazepines and z-drugs, Lactium produces no daytime sedation, no addiction potential, and no withdrawal effects. Works through GABA-A receptor modulation but at a different binding site that doesn't trigger the dependence pathway. Reasonable first-line option to try before pharmaceutical anxiolytics for mild-to-moderate stress and sleep difficulty. Effect size is smaller than benzodiazepines but the safety profile is dramatically better.

Mechanism of action

1

GABA-A benzodiazepine site binding (unique peptide mechanism)

α-casozepine binds to the benzodiazepine binding site on GABA-A receptors, the same target as diazepam, valium, and alprazolam, showing benzodiazepine-like activity. It is unique in binding the benzodiazepine site without benzodiazepine side effects (no dependence, sedation, motor impairment, or cognitive impairment). This is the mechanism for safe daytime stress reduction plus evening sleep support.

2

Cortisol reduction

Reduces cortisol levels in response to stress. Mechanism via central effects on HPA axis through GABA-A modulation. Clinically meaningful for chronic stress states where elevated cortisol contributes to sleep problems and metabolic dysfunction.

3

Faster stress recovery (autonomic)

Faster autonomic recovery (BP, HR) after stressors has been demonstrated. Mechanism: GABA-A modulation reduces the duration of sympathetic nervous system activation. The practical benefit is faster physiological return to baseline after stressful events.

4

Tryptic hydrolysis releases active peptide

α-casozepine is naturally released during digestion of milk casein — explains observation of calmed infants after milk feeding. Lactium® manufactures the bioactive peptide via controlled tryptic hydrolysis of bovine αs1-casein. Mechanism: bypasses gastric digestion variability.

5

BBB penetration (small peptide)

Decapeptide size enables BBB crossing for direct CNS effects. Lipophilicity sufficient for passive transport. Mechanism for rapid onset (30-60 min) stress effects.

6

Combined synergy with L-theanine, Zizyphus, B6

Multiple clinical trials demonstrate Lactium synergy with: L-theanine (alpha-wave modulation), Zizyphus (saponin-mediated GABA effects), vitamin B6 (cofactor for GABA synthesis). Mechanism complementary to direct GABA-A modulation. Supports stack/combination protocols.

Clinical trials

1
α-Casozepine Foundational Characterization

Foundational pharmacological characterization (Miclo L, Perrin E, Driou A, Papadopoulos V, Boujrad N, Vanderesse R, Boudier JF, Desor D, Linden G, Gaillard JL 2001, FASEB J 15(10):1780-1782, doi:10.1096/fj.00-0685fje).

In vitro and animal pharmacological characterization of α-casozepine peptide identified from bovine αs1-casein tryptic hydrolysate.

Established α-casozepine as tryptic peptide from bovine αs1-CASEIN with benzodiazepine-like activity. Foundational discovery enabling subsequent clinical development of Lactium®. Demonstrated GABA-A receptor benzodiazepine site binding affinity.

2
Lactium Stress Recovery in Healthy Volunteers

Clinical hemodynamic stress response trial (Messaoudi M, Lefranc-Millot C, Desor D, Demagny B, Eur J Nutr 44(2):128-132, doi:10.1007/s00394-004-0534-7).

Healthy human volunteers facing successive mental and physical stress situations. Pre/post Lactium intake hemodynamic monitoring.

Lactium promoted faster stress recovery — lower blood pressure and heart rate during relaxation period (after stress) vs rest period (before stress induction). Demonstrated autonomic stress recovery benefits in healthy population. Foundational stress response evidence.

3
Lactium Chronic Insomnia 4-Week Clinical Trial

Randomized double-blind placebo-controlled trial (Lee 2024, Clinical Nutrition ESPEN, doi:10.1016/j.clnesp.2024.10.001, ScienceDirect).

Individuals with chronic insomnia. Lactium® (Alpha-s1 casein hydrolysate) vs placebo for 4 weeks. Subjective measures: ISI, GSDS, PSQI, ESS, HADS. Objective measures: polysomnography (PSG).

4-WEEK intervention measured both subjective sleep quality and objective polysomnographic parameters. Sleep onset latency reduction targeted as primary mechanism. Combined subjective + objective methodology provides robust evidence framework. Recent rigorous chronic insomnia trial.

Side effects and drug interactions

Common Potential side effects

Generally extremely well-tolerated — derived from food protein.
GI upset (rare).
NO sedation, NO dependence, NO motor impairment, NO cognitive impairment, NO withdrawal — major advantages over benzodiazepines.
Allergic reactions in milk-protein-allergic individuals (rare; peptide hydrolysate may still trigger casein allergy).
Pregnancy/lactation: limited specific data; food-grade origin supports general safety at typical doses.
Long-term safety: extensive food consumption + multiple clinical trials supportive.
Lactose-free (peptide hydrolysate without lactose).

Important Drug interactions

Benzodiazepines: theoretical synergistic effects (same receptor site) — monitor for excessive sedation if combined.
Other GABA-A modulators (zolpidem, eszopiclone, baclofen): theoretical additive effects.
Alcohol: theoretical additive sedation; avoid combination especially at high alcohol intake.
Antidepressants (SSRIs): generally compatible.
Most medications: well-tolerated combination profile.
L-theanine, Zizyphus, vitamin B6: synergistic sleep/stress effects — evidence-based combinations.

Frequently asked questions about Lactium® (Alpha-Casozepine Milk Peptide)

What is Lactium?

Branded milk-derived bioactive peptide from Ingredia Nutritional (France). A tryptic hydrolysate of bovine αs1-casein containing the α-casozepine decapeptide with benzodiazepine-like activity, discovered by observing infants' calmed state after milk feeding.

What is Lactium used for?

Lactium is researched primarily for Stress & Anxiety, Sleep Health, and Mood & Mental Health. Lactium at 150-300 mg/day reduces perceived stress and anxiety scores in healthy adults experiencing work or life stress. The signature finding is faster physiological recovery from stress — blood pressure and heart rate return to baseline…

What is the recommended dosage of Lactium?

The clinically studied dose is 150–300 mg/day (AM/PM split or evening for sleep); 300 mg/day for insomnia; 150 mg single dose for acute stress. Always follow the product label and check with a healthcare provider for personal advice.

Is Lactium safe, and does it have side effects?

For most healthy adults, Lactium is well tolerated at studied doses. Reported effects can include: Generally extremely well-tolerated — derived from food protein. GI upset (rare). It may also interact with some medications. Lactium is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Lactium interact with any medications?

Possible interactions include: Benzodiazepines: theoretical synergistic effects (same receptor site) — monitor for excessive sedation if combined. Other GABA-A modulators (zolpidem, eszopiclone, baclofen): theoretical additive effects. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Lactium?

NutraSmarts rates the evidence for Lactium as Limited (2 out of 5). It is backed by 3 clinical trials and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Chang CM, Tsai IJ, Yang CC, Liu WC, Yang CP The impact of Alpha-s1 Casein hydrolysate on chronic insomnia: A randomized, double-blind controlled trial Clinical Nutrition. 2024;43(12):275-284. doi:10.1016/j.clnu.2024.10.039.PubMedUsed to support: 4-week double-blind RCT of Lactium® (alpha-s1 casein hydrolysate) 300 mg/day in chronic insomnia patients (n=36): significant improvements on ISI, GSDS, PSQI, ESS, and HADS; polysomnography showed reduced sleep onset latency (~7.7 min). Supports chronic insomnia improvement and faster stress/sleep recovery.
  2. Kim HJ, Kim J, Lee S, Kim B, Kwon E, Lee JE, Chun MY, Lee CY, Boulier A, Oh S, Lee HW A Double-Blind, Randomized, Placebo-Controlled Crossover Clinical Study of the Effects of Alpha-s1 Casein Hydrolysate on Sleep Disturbance Nutrients. 2019;11(7):1466. doi:10.3390/nu11071466.PubMedUsed to support: 4-week crossover RCT of alpha-s1 casein hydrolysate (Lactium® active): sleep diaries showed increased total sleep time, improved sleep efficiency, decreased sleep onset latency; actigraphy confirmed significantly enhanced sleep efficiency at 4 weeks. Supports sleep disturbance improvement in crossover design.
  3. Miclo L, Perrin E, Driou A, Papadopoulos V, Boujrad N, Vanderesse R, Boudier JF, Desor D, Linden G, Gaillard JL Characterization of alpha-casozepine, a tryptic peptide from bovine alpha(s1)-casein with benzodiazepine-like activity FASEB Journal. 2001;15(10):1780-2. doi:10.1096/fj.00-0685fje.PubMedUsed to support: Foundational characterization of alpha-casozepine (the active decapeptide in Lactium®): demonstrates benzodiazepine-like binding activity derived from bovine αs1-casein tryptic hydrolysis. Supports the GABA/benzodiazepine receptor mechanism underlying Lactium's anxiolytic and sleep effects.